BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s stock price rose 6.1% during trading on Friday . The stock traded as high as $3.64 and last traded at $3.64. Approximately 6,961,500 shares traded hands during mid-day trading, a decline of 9% from the average daily volume of 7,646,306 shares. The stock had previously closed at $3.43.
BCRX has been the subject of several research analyst reports. HC Wainwright restated a “buy” rating and issued a $13.00 price target on shares of BioCryst Pharmaceuticals in a research report on Friday, August 7th. ValuEngine downgraded shares of BioCryst Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Thursday, July 2nd. BidaskClub downgraded shares of BioCryst Pharmaceuticals from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 25th. BTIG Research initiated coverage on shares of BioCryst Pharmaceuticals in a research report on Tuesday, June 16th. They